Anastrozole is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausal women. The severity of breast cancer can be increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastro

zole works by inhibiting the synthesis of estrogen. 

Properties
Appearance & Physical State: crystalline solid
Density: 1.08 g/cm3
Melting Point: 81-82oC
Boiling Point: 469.7oC at 760 mmHg
Refractive Index: 1.791
Storage Condition: Store in original container in a cool dark place.

HOT SELLING

Semaglutide CAS 910463-68-2

Tirzepatide CAS 2023788-19-2

Retatrutide CAS 2381089-83-2

Liaglutide CAS 204656-20-2

Octreotide CAS79517-01-4

Dulaglutide CAS 923950-08-7

LixisenatideAcetate CAS 320367-13-3

Teduglutide CAS 197922-42-2

Albiglutide CAS 782500-75-8

Degarelix CAS 214766-78-6

Cilengitide CAS 188968-51-6

Mifamurtide CAS 83461-56-7

Somatostatin CAS 51110-01-1

Exenatide Acetate CAS 141732-76-5

Pramlintide CAS 151126-32-8

Eptifibatide CAS 188627-80-7

Bivalirudin CAS 128270-60-0

Semax CAS 80714-61-0